Search
Now showing items 1-1 of 1
Role of mTORC1 in BDK-Mediated Improvements in Cardiometabolic Parameters
(2022-04-21)
Multiple recent studies from various labs have shown improvements in several endpoints in pre-clinical models after treatment with the branched chain ketoacid dehydrogenase kinase (BDK) inhibitor BT2, yet there is still a ...